Scios Overhauls Natrecor Physician Promotion
This article was originally published in The Pink Sheet Daily
Executive Summary
The Johnson & Johnson subsidiary's program for its congestive heart failure agent includes sales force training and new promotional materials that reflect expert panel recommendations on nesiritide use.